Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
MAIA
)
2.857
-0.043 (-1.47%)
Streaming Delayed Price
Updated: 10:32 AM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
25,158
Open
2.910
Bid (Size)
2.850 (1)
Ask (Size)
3.000 (36)
Prev. Close
2.900
Today's Range
2.700 - 2.980
52wk Range
0.8200 - 5.990
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q2 2024
August 16, 2024
MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
MAIA Biotechnology (MAIA) is one of the earliest pioneers of telomere targeting as a therapeutic strategy
July 23, 2024
Via
AB Newswire
Exposures
Product Safety
Performance
YTD
+140.12%
+140.12%
1 Month
-11.81%
-11.81%
3 Month
-30.48%
-30.48%
6 Month
+108.57%
+108.57%
1 Year
+51.19%
+51.19%
More News
Read More
MAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced Patients
July 23, 2024
Via
Benzinga
Why SAP Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
July 23, 2024
Via
Benzinga
MAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment Agent
July 23, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
FDA move illuminates key role of telomere targeting as a viable therapeutic strategy for cancer treatment
July 09, 2024
Via
AB Newswire
Exposures
COVID-19
Product Safety
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 07, 2024
Via
Benzinga
MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
June 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
New Clinical Data Reveals MAIA Biotechnology's THIO Achieves High Efficacy In Advanced Non-Small Cell Lung Cancer Treatment
June 07, 2024
Via
News Direct
Topics
Death
Exposures
Death
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
June 07, 2024
Via
AB Newswire
MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
June 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
Groundbreaking Study by MAIA Biotechnology (NYSE: MAIA) Indicates Promising New Treatment for Advanced Lung Cancer
June 06, 2024
Via
AB Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 04, 2024
Via
Benzinga
MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
June 04, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024
June 04, 2024
Via
AB Newswire
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
May 31, 2024
Via
AB Newswire
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market
May 22, 2024
Via
News Direct
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
May 21, 2024
Via
AB Newswire
MAIA Biotechnology to Present at the BIO International Convention 2024
May 17, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
May 16, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024
May 15, 2024
Via
InvestorPlace
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
April 30, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
April 29, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces $1.00 Million Private Placement
April 23, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.